LATEST
Scientists Launch Legal Challenge to DEA's Proposed Psychedelic Scheduling, Which Would Criminalize Research Compounds and Jeopardize FDA Breakthrough Therapy for Postpartum DepressionTrauma Nurse Builds Clinical Apps Between ShiftsObama Criticises Israel as His Own Record Comes Under ScrutinyVIORA and BioTeke Strengthen Strategic Partnership to Advance Saliva Pregnancy Testing Across EuropeAI Startup AvalonX Emerges From Stealth With $10 Million in Funding From Ridown CapitalGaza, the October 7 Warnings and the Human Cost of Israel’s Security StrategyWhy Good Strategies Lose Momentum Before the Numbers Show It'Our Islands Are Under Threat': Locals Urge King Charles to Help Save Bahamas Reefs Ahead of Commonwealth SummitTransatlantic Coalition: European and Canadian News and Magazine Publishers Unite to Defend Free and Pluralistic MediaDan Rather, Wavelength, Original Productions and Anchor Entertainment Partner to Make RATHER Documentary Free to Stream on YouTube Beginning Monday, October 26, in Support of Independent Journalism and Free SpeechScientists Launch Legal Challenge to DEA's Proposed Psychedelic Scheduling, Which Would Criminalize Research Compounds and Jeopardize FDA Breakthrough Therapy for Postpartum DepressionTrauma Nurse Builds Clinical Apps Between ShiftsObama Criticises Israel as His Own Record Comes Under ScrutinyVIORA and BioTeke Strengthen Strategic Partnership to Advance Saliva Pregnancy Testing Across EuropeAI Startup AvalonX Emerges From Stealth With $10 Million in Funding From Ridown CapitalGaza, the October 7 Warnings and the Human Cost of Israel’s Security StrategyWhy Good Strategies Lose Momentum Before the Numbers Show It'Our Islands Are Under Threat': Locals Urge King Charles to Help Save Bahamas Reefs Ahead of Commonwealth SummitTransatlantic Coalition: European and Canadian News and Magazine Publishers Unite to Defend Free and Pluralistic MediaDan Rather, Wavelength, Original Productions and Anchor Entertainment Partner to Make RATHER Documentary Free to Stream on YouTube Beginning Monday, October 26, in Support of Independent Journalism and Free Speech
Health

Boulder Diagnostics Announces the European Market Launch for Its ParaFlor™ Parasite Detection Kits.

Richard Powell  1 min read
Illustration: greatreporter

Boulder Diagnostics Inc. announced today the European market launch of its ParaFlor™ kits for the detection of Giardia, Cryptosporidium and Blastocystis infections for human and veterinary applications.

The rapid assays enable detection in less than ten minutes in both fresh and fixed stool samples and are also available for veterinary applications and Research Use Only in humans in the US. The ParaFlor B kit is the first specific assay for the detection of the Blastocystis parasite.

“We are pleased to contribute to the debate over the role of Blastocystis infections in persistent gastrointestinal disorders with our novel and highly specific ParaFlor assay kit”, comments Dr. Wolfgang Pieken, President and CEO of Boulder Diagnostics Inc.

A study by Dr. Ronald Fayer of the US Department of Agriculture-ARS, Beltsville, MD on the presence of Blastocystis in cattle noted the accuracy and practicality of this immunofluorescence (IFA) assay method as compared to PCR. (Fayer et al, 2012, Parasitol Research vol 111, 1349 – 55.)

“ParaFlor parasite detection kits are available worldwide for order on our web site, www.BoulderDiagnostics.com” , remarks Dede Willis, COO of Boulder Diagnostics Inc.

Boulder Diagnostics Inc. is an in vitro diagnostics company that focuses on identifying, developing, and marketing new diagnostic technologies for underserved markets. In addition to the ParaFlor™ kits for parasite detection, Boulder Diagnostics currently offers the SpiroFind™ assay for detection of active Lyme disease.

Related articles

Top